img

Global Hemostatic Agents Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hemostatic Agents Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Hemostatic Agents report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hemostatic Agents market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Surgical Centers are the major drivers for the industry.
The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemostatic Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others

Segment by Application


Hospitals
Surgical Centers
Nursing Homes

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Hemostatic Agents market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hemostatic Agents, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hemostatic Agents industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hemostatic Agents in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hemostatic Agents introduction, etc. Hemostatic Agents Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hemostatic Agents market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Hemostatic Agents Market Overview
1.1 Hemostatic Agents Product Overview
1.2 Hemostatic Agents Market Segment by Type
1.2.1 Gelation Sponge
1.2.2 Oxidized Regenerated Cellulose Based Hemostats
1.2.3 Others
1.3 Global Hemostatic Agents Market Size by Type
1.3.1 Global Hemostatic Agents Market Size Overview by Type (2018-2034)
1.3.2 Global Hemostatic Agents Historic Market Size Review by Type (2018-2024)
1.3.3 Global Hemostatic Agents Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hemostatic Agents Sales Breakdown by Type (2018-2024)
1.4.2 Europe Hemostatic Agents Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Hemostatic Agents Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Hemostatic Agents Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Hemostatic Agents Sales Breakdown by Type (2018-2024)
2 Global Hemostatic Agents Market Competition by Company
2.1 Global Top Players by Hemostatic Agents Sales (2018-2024)
2.2 Global Top Players by Hemostatic Agents Revenue (2018-2024)
2.3 Global Top Players by Hemostatic Agents Price (2018-2024)
2.4 Global Top Manufacturers Hemostatic Agents Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hemostatic Agents Market Competitive Situation and Trends
2.5.1 Hemostatic Agents Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Hemostatic Agents Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemostatic Agents as of 2022)
2.7 Date of Key Manufacturers Enter into Hemostatic Agents Market
2.8 Key Manufacturers Hemostatic Agents Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hemostatic Agents Status and Outlook by Region
3.1 Global Hemostatic Agents Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Hemostatic Agents Historic Market Size by Region
3.2.1 Global Hemostatic Agents Sales in Volume by Region (2018-2024)
3.2.2 Global Hemostatic Agents Sales in Value by Region (2018-2024)
3.2.3 Global Hemostatic Agents Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Hemostatic Agents Forecasted Market Size by Region
3.3.1 Global Hemostatic Agents Sales in Volume by Region (2024-2034)
3.3.2 Global Hemostatic Agents Sales in Value by Region (2024-2034)
3.3.3 Global Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Hemostatic Agents by Application
4.1 Hemostatic Agents Market Segment by Application
4.1.1 Hospitals
4.1.2 Surgical Centers
4.1.3 Nursing Homes
4.2 Global Hemostatic Agents Market Size by Application
4.2.1 Global Hemostatic Agents Market Size Overview by Application (2018-2034)
4.2.2 Global Hemostatic Agents Historic Market Size Review by Application (2018-2024)
4.2.3 Global Hemostatic Agents Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hemostatic Agents Sales Breakdown by Application (2018-2024)
4.3.2 Europe Hemostatic Agents Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Hemostatic Agents Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Hemostatic Agents Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Hemostatic Agents Sales Breakdown by Application (2018-2024)
5 North America Hemostatic Agents by Country
5.1 North America Hemostatic Agents Historic Market Size by Country
5.1.1 North America Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Hemostatic Agents Sales in Volume by Country (2018-2024)
5.1.3 North America Hemostatic Agents Sales in Value by Country (2018-2024)
5.2 North America Hemostatic Agents Forecasted Market Size by Country
5.2.1 North America Hemostatic Agents Sales in Volume by Country (2024-2034)
5.2.2 North America Hemostatic Agents Sales in Value by Country (2024-2034)
6 Europe Hemostatic Agents by Country
6.1 Europe Hemostatic Agents Historic Market Size by Country
6.1.1 Europe Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Hemostatic Agents Sales in Volume by Country (2018-2024)
6.1.3 Europe Hemostatic Agents Sales in Value by Country (2018-2024)
6.2 Europe Hemostatic Agents Forecasted Market Size by Country
6.2.1 Europe Hemostatic Agents Sales in Volume by Country (2024-2034)
6.2.2 Europe Hemostatic Agents Sales in Value by Country (2024-2034)
7 Asia-Pacific Hemostatic Agents by Region
7.1 Asia-Pacific Hemostatic Agents Historic Market Size by Region
7.1.1 Asia-Pacific Hemostatic Agents Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Hemostatic Agents Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Hemostatic Agents Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Hemostatic Agents Forecasted Market Size by Region
7.2.1 Asia-Pacific Hemostatic Agents Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Hemostatic Agents Sales in Value by Region (2024-2034)
8 Latin America Hemostatic Agents by Country
8.1 Latin America Hemostatic Agents Historic Market Size by Country
8.1.1 Latin America Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Hemostatic Agents Sales in Volume by Country (2018-2024)
8.1.3 Latin America Hemostatic Agents Sales in Value by Country (2018-2024)
8.2 Latin America Hemostatic Agents Forecasted Market Size by Country
8.2.1 Latin America Hemostatic Agents Sales in Volume by Country (2024-2034)
8.2.2 Latin America Hemostatic Agents Sales in Value by Country (2024-2034)
9 Middle East and Africa Hemostatic Agents by Country
9.1 Middle East and Africa Hemostatic Agents Historic Market Size by Country
9.1.1 Middle East and Africa Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Hemostatic Agents Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Hemostatic Agents Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Hemostatic Agents Forecasted Market Size by Country
9.2.1 Middle East and Africa Hemostatic Agents Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Hemostatic Agents Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Ethicon
10.1.1 Ethicon Company Information
10.1.2 Ethicon Introduction and Business Overview
10.1.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Ethicon Hemostatic Agents Products Offered
10.1.5 Ethicon Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Hemostatic Agents Products Offered
10.2.5 Pfizer Recent Development
10.3 Baxter International
10.3.1 Baxter International Company Information
10.3.2 Baxter International Introduction and Business Overview
10.3.3 Baxter International Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Baxter International Hemostatic Agents Products Offered
10.3.5 Baxter International Recent Development
10.4 C. R. Bard
10.4.1 C. R. Bard Company Information
10.4.2 C. R. Bard Introduction and Business Overview
10.4.3 C. R. Bard Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.4.4 C. R. Bard Hemostatic Agents Products Offered
10.4.5 C. R. Bard Recent Development
10.5 The Medicines Company
10.5.1 The Medicines Company Company Information
10.5.2 The Medicines Company Introduction and Business Overview
10.5.3 The Medicines Company Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.5.4 The Medicines Company Hemostatic Agents Products Offered
10.5.5 The Medicines Company Recent Development
10.6 Anika Therapeutics
10.6.1 Anika Therapeutics Company Information
10.6.2 Anika Therapeutics Introduction and Business Overview
10.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Anika Therapeutics Hemostatic Agents Products Offered
10.6.5 Anika Therapeutics Recent Development
10.7 Advanced Medical Solutions
10.7.1 Advanced Medical Solutions Company Information
10.7.2 Advanced Medical Solutions Introduction and Business Overview
10.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Advanced Medical Solutions Hemostatic Agents Products Offered
10.7.5 Advanced Medical Solutions Recent Development
10.8 Integra LifeSciences
10.8.1 Integra LifeSciences Company Information
10.8.2 Integra LifeSciences Introduction and Business Overview
10.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Integra LifeSciences Hemostatic Agents Products Offered
10.8.5 Integra LifeSciences Recent Development
10.9 B Braun Melsungen
10.9.1 B Braun Melsungen Company Information
10.9.2 B Braun Melsungen Introduction and Business Overview
10.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.9.4 B Braun Melsungen Hemostatic Agents Products Offered
10.9.5 B Braun Melsungen Recent Development
10.10 Gelita Medical
10.10.1 Gelita Medical Company Information
10.10.2 Gelita Medical Introduction and Business Overview
10.10.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Gelita Medical Hemostatic Agents Products Offered
10.10.5 Gelita Medical Recent Development
10.11 Equimedical
10.11.1 Equimedical Company Information
10.11.2 Equimedical Introduction and Business Overview
10.11.3 Equimedical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Equimedical Hemostatic Agents Products Offered
10.11.5 Equimedical Recent Development
10.12 Vascular Solutions
10.12.1 Vascular Solutions Company Information
10.12.2 Vascular Solutions Introduction and Business Overview
10.12.3 Vascular Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Vascular Solutions Hemostatic Agents Products Offered
10.12.5 Vascular Solutions Recent Development
10.13 Marine Polymer Technologies
10.13.1 Marine Polymer Technologies Company Information
10.13.2 Marine Polymer Technologies Introduction and Business Overview
10.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Marine Polymer Technologies Hemostatic Agents Products Offered
10.13.5 Marine Polymer Technologies Recent Development
10.14 Z-Medica
10.14.1 Z-Medica Company Information
10.14.2 Z-Medica Introduction and Business Overview
10.14.3 Z-Medica Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Z-Medica Hemostatic Agents Products Offered
10.14.5 Z-Medica Recent Development
10.15 CryoLife
10.15.1 CryoLife Company Information
10.15.2 CryoLife Introduction and Business Overview
10.15.3 CryoLife Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.15.4 CryoLife Hemostatic Agents Products Offered
10.15.5 CryoLife Recent Development
10.16 BioCer Entwicklungs
10.16.1 BioCer Entwicklungs Company Information
10.16.2 BioCer Entwicklungs Introduction and Business Overview
10.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.16.4 BioCer Entwicklungs Hemostatic Agents Products Offered
10.16.5 BioCer Entwicklungs Recent Development
10.17 Biom’Up SAS
10.17.1 Biom’Up SAS Company Information
10.17.2 Biom’Up SAS Introduction and Business Overview
10.17.3 Biom’Up SAS Hemostatic Agents Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Biom’Up SAS Hemostatic Agents Products Offered
10.17.5 Biom’Up SAS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hemostatic Agents Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hemostatic Agents Industrial Chain Analysis
11.4 Hemostatic Agents Market Dynamics
11.4.1 Hemostatic Agents Industry Trends
11.4.2 Hemostatic Agents Market Drivers
11.4.3 Hemostatic Agents Market Challenges
11.4.4 Hemostatic Agents Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hemostatic Agents Distributors
12.3 Hemostatic Agents Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Gelation Sponge
Table 2. Major Company of Oxidized Regenerated Cellulose Based Hemostats
Table 3. Major Company of Others
Table 4. Global Hemostatic Agents Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Hemostatic Agents Sales by Type (2018-2024) & (K Units)
Table 6. Global Hemostatic Agents Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Hemostatic Agents Sales by Type (2018-2024) & (US& Million)
Table 8. Global Hemostatic Agents Market Share in Value by Type (2018-2024)
Table 9. Global Hemostatic Agents Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Hemostatic Agents Sales by Type (2024-2034) & (K Units)
Table 11. Global Hemostatic Agents Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Hemostatic Agents Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Hemostatic Agents Sales Market Share in Value by Type (2024-2034)
Table 14. Global Hemostatic Agents Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Hemostatic Agents Sales by Type (2018-2024) & (K Units)
Table 16. North America Hemostatic Agents Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Hemostatic Agents Sales (K Units) by Type (2018-2024)
Table 18. Europe Hemostatic Agents Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Hemostatic Agents Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Hemostatic Agents Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Hemostatic Agents Sales (K Units) by Type (2018-2024)
Table 22. Latin America Hemostatic Agents Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Hemostatic Agents Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Hemostatic Agents Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Hemostatic Agents Sales by Company (2018-2024) & (K Units)
Table 26. Global Hemostatic Agents Sales Share by Company (2018-2024)
Table 27. Global Hemostatic Agents Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Hemostatic Agents Revenue Share by Company (2018-2024)
Table 29. Global Market Hemostatic Agents Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Hemostatic Agents Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemostatic Agents as of 2022)
Table 33. Date of Key Manufacturers Enter into Hemostatic Agents Market
Table 34. Key Manufacturers Hemostatic Agents Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Hemostatic Agents Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Hemostatic Agents Sales by Region (2018-2024) & (K Units)
Table 38. Global Hemostatic Agents Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Hemostatic Agents Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Hemostatic Agents Sales Market Share in Value by Region (2018-2024)
Table 41. Global Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Hemostatic Agents Sales by Region (2024-2034) & (K Units)
Table 43. Global Hemostatic Agents Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Hemostatic Agents Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Hemostatic Agents Sales Market Share in Value by Region (2024-2034)
Table 46. Global Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Hemostatic Agents Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Hemostatic Agents Sales by Application (2018-2024) & (K Units)
Table 49. Global Hemostatic Agents Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Hemostatic Agents Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Hemostatic Agents Sales Market Share in Value by Application (2018-2024)
Table 52. Global Hemostatic Agents Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Hemostatic Agents Sales by Application (2024-2034) & (K Units)
Table 54. Global Hemostatic Agents Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Hemostatic Agents Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Hemostatic Agents Sales Market Share in Value by Application (2024-2034)
Table 57. Global Hemostatic Agents Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Hemostatic Agents Sales by Application (2018-2024) (K Units)
Table 59. North America Hemostatic Agents Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Hemostatic Agents Sales by Application (2018-2024) (K Units)
Table 61. Europe Hemostatic Agents Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Hemostatic Agents Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Hemostatic Agents Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Hemostatic Agents Sales by Application (2018-2024) (K Units)
Table 65. Latin America Hemostatic Agents Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Hemostatic Agents Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Hemostatic Agents Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Hemostatic Agents Sales by Country (2018-2024) & (K Units)
Table 69. North America Hemostatic Agents Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Hemostatic Agents Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Hemostatic Agents Sales Market Share in Value by Country (2018-2024)
Table 72. North America Hemostatic Agents Sales by Country (2024-2034) & (K Units)
Table 73. North America Hemostatic Agents Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Hemostatic Agents Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Hemostatic Agents Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Hemostatic Agents Sales by Country (2018-2024) & (K Units)
Table 77. Europe Hemostatic Agents Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Hemostatic Agents Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Hemostatic Agents Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Hemostatic Agents Sales by Country (2024-2034) & (K Units)
Table 81. Europe Hemostatic Agents Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Hemostatic Agents Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Hemostatic Agents Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Hemostatic Agents Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Hemostatic Agents Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Hemostatic Agents Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Hemostatic Agents Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Hemostatic Agents Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Hemostatic Agents Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Hemostatic Agents Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Hemostatic Agents Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Hemostatic Agents Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Hemostatic Agents Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Hemostatic Agents Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Hemostatic Agents Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Hemostatic Agents Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Hemostatic Agents Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Hemostatic Agents Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Hemostatic Agents Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Hemostatic Agents Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Hemostatic Agents Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Hemostatic Agents Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Hemostatic Agents Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Hemostatic Agents Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Hemostatic Agents Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Hemostatic Agents Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Hemostatic Agents Sales Market Share in Value by Country (2024-2034)
Table 108. Ethicon Company Information
Table 109. Ethicon Introduction and Business Overview
Table 110. Ethicon Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Ethicon Hemostatic Agents Product
Table 112. Ethicon Recent Development
Table 113. Pfizer Company Information
Table 114. Pfizer Introduction and Business Overview
Table 115. Pfizer Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Pfizer Hemostatic Agents Product
Table 117. Pfizer Recent Development
Table 118. Baxter International Company Information
Table 119. Baxter International Introduction and Business Overview
Table 120. Baxter International Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Baxter International Hemostatic Agents Product
Table 122. Baxter International Recent Development
Table 123. C. R. Bard Company Information
Table 124. C. R. Bard Introduction and Business Overview
Table 125. C. R. Bard Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. C. R. Bard Hemostatic Agents Product
Table 127. C. R. Bard Recent Development
Table 128. The Medicines Company Company Information
Table 129. The Medicines Company Introduction and Business Overview
Table 130. The Medicines Company Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. The Medicines Company Hemostatic Agents Product
Table 132. The Medicines Company Recent Development
Table 133. Anika Therapeutics Company Information
Table 134. Anika Therapeutics Introduction and Business Overview
Table 135. Anika Therapeutics Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Anika Therapeutics Hemostatic Agents Product
Table 137. Anika Therapeutics Recent Development
Table 138. Advanced Medical Solutions Company Information
Table 139. Advanced Medical Solutions Introduction and Business Overview
Table 140. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Advanced Medical Solutions Hemostatic Agents Product
Table 142. Advanced Medical Solutions Recent Development
Table 143. Integra LifeSciences Company Information
Table 144. Integra LifeSciences Introduction and Business Overview
Table 145. Integra LifeSciences Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Integra LifeSciences Hemostatic Agents Product
Table 147. Integra LifeSciences Recent Development
Table 148. B Braun Melsungen Company Information
Table 149. B Braun Melsungen Introduction and Business Overview
Table 150. B Braun Melsungen Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. B Braun Melsungen Hemostatic Agents Product
Table 152. B Braun Melsungen Recent Development
Table 153. Gelita Medical Company Information
Table 154. Gelita Medical Introduction and Business Overview
Table 155. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Gelita Medical Hemostatic Agents Product
Table 157. Gelita Medical Recent Development
Table 158. Equimedical Company Information
Table 159. Equimedical Introduction and Business Overview
Table 160. Equimedical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Equimedical Hemostatic Agents Product
Table 162. Equimedical Recent Development
Table 163. Vascular Solutions Company Information
Table 164. Vascular Solutions Introduction and Business Overview
Table 165. Vascular Solutions Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Vascular Solutions Hemostatic Agents Product
Table 167. Vascular Solutions Recent Development
Table 168. Marine Polymer Technologies Company Information
Table 169. Marine Polymer Technologies Introduction and Business Overview
Table 170. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Marine Polymer Technologies Hemostatic Agents Product
Table 172. Marine Polymer Technologies Recent Development
Table 173. Z-Medica Company Information
Table 174. Z-Medica Introduction and Business Overview
Table 175. Z-Medica Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Z-Medica Hemostatic Agents Product
Table 177. Z-Medica Recent Development
Table 178. CryoLife Company Information
Table 179. CryoLife Introduction and Business Overview
Table 180. CryoLife Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. CryoLife Hemostatic Agents Product
Table 182. CryoLife Recent Development
Table 183. BioCer Entwicklungs Company Information
Table 184. BioCer Entwicklungs Introduction and Business Overview
Table 185. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. BioCer Entwicklungs Hemostatic Agents Product
Table 187. BioCer Entwicklungs Recent Development
Table 188. Biom’Up SAS Company Information
Table 189. Biom’Up SAS Introduction and Business Overview
Table 190. Biom’Up SAS Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Biom’Up SAS Hemostatic Agents Product
Table 192. Biom’Up SAS Recent Development
Table 193. Key Raw Materials Lists
Table 194. Raw Materials Key Suppliers Lists
Table 195. Hemostatic Agents Market Trends
Table 196. Hemostatic Agents Market Drivers
Table 197. Hemostatic Agents Market Challenges
Table 198. Hemostatic Agents Market Restraints
Table 199. Hemostatic Agents Distributors List
Table 200. Hemostatic Agents Downstream Customers
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostatic Agents Product Picture
Figure 2. Global Hemostatic Agents Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Hemostatic Agents Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Hemostatic Agents Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Gelation Sponge
Figure 6. Global Gelation Sponge Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Oxidized Regenerated Cellulose Based Hemostats
Figure 8. Global Oxidized Regenerated Cellulose Based Hemostats Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Hemostatic Agents Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Hemostatic Agents Sales Market Share by Type in 2022 & 2034
Figure 13. North America Hemostatic Agents Sales Market Share in Volume by Type in 2022
Figure 14. North America Hemostatic Agents Sales Market Share in Value by Type in 2022
Figure 15. Europe Hemostatic Agents Sales Market Share in Volume by Type in 2022
Figure 16. Europe Hemostatic Agents Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Hemostatic Agents Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Hemostatic Agents Sales Market Share in Value by Type in 2022
Figure 19. Latin America Hemostatic Agents Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Hemostatic Agents Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Hemostatic Agents Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Hemostatic Agents Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Hemostatic Agents Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Hemostatic Agents Revenue in 2022
Figure 25. Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospitals
Figure 27. Global Hospitals Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Surgical Centers
Figure 29. Global Surgical Centers Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Nursing Homes
Figure 31. Global Nursing Homes Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Hemostatic Agents Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Hemostatic Agents Sales Market Share by Application in 2022 & 2034
Figure 34. North America Hemostatic Agents Sales Market Share in Volume by Application in 2022
Figure 35. North America Hemostatic Agents Sales Market Share in Value by Application in 2022
Figure 36. Europe Hemostatic Agents Sales Market Share in Volume by Application in 2022
Figure 37. Europe Hemostatic Agents Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Hemostatic Agents Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Hemostatic Agents Sales Market Share in Value by Application in 2022
Figure 40. Latin America Hemostatic Agents Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Hemostatic Agents Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Hemostatic Agents Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Hemostatic Agents Manufacturing Cost Structure
Figure 45. Hemostatic Agents Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed